Nitric Oxide Delivered to First Patient Enrolled in Phase 2 Trial for Serious Respiratory Infection
News
The first patient enrolled in a Phase 2 trial for patients with a serious infection — Mycobacterium abscessus complex (MABSC) — has successfully received the first dose of nitric oxide ... Read more